Elanco Animal Health INC Form 4 insider transactions

Rajeev A. Modi, an executive at Elanco Animal Health, reported the acquisition of restricted stock units and stock options, as well as deferred stock units.

Shiv O'Neill, GC AND CORP SEC of Elanco Animal Health, reports the acquisition of restricted stock units and stock options.

Elanco Animal Health's Executive Vice President, Ramiro Martin Cabral, was granted restricted stock units and stock options on March 3, 2025.

James M. Meer, Chief Accounting Officer of Elanco Animal Health, reports the acquisition of restricted stock units and disposal of common stock.

David S. Kinard, an Executive Vice President at Elanco Animal Health, was granted stock options and restricted stock units on March 3, 2025.

Grace McArdle, EVP of Manufacturing and Quality at Elanco Animal Health, reports the acquisition of stock options and restricted stock units.

Todd S. Young, Executive Vice President and CFO of Elanco Animal Health, reports transactions involving company stock, including acquisitions, disposals, and gifts, affecting both direct and indirect ownership.

Executive Vice President Timothy J. Bettington of Elanco Animal Health Inc. reports the disposal of 3,514 shares of common stock to cover tax obligations.

Elanco Animal Health CEO Jeffrey Simmons disposed of 75,721 shares of common stock to cover tax obligations, while still holding a significant number of shares directly and indirectly.

Shiv O'Neill, GC AND CORP SEC of Elanco Animal Health Inc, reports the disposal of 3,879 shares of common stock to cover tax obligations.

Rajeev A. Modi, an executive at Elanco Animal Health, reported disposing of 6,557 shares of common stock to cover tax obligations.

James M. Meer, Chief Accounting Officer of Elanco Animal Health Inc, reported the disposal of 2,356 shares of common stock on March 1, 2025.

Jose Manuel Correia de Simas, an Executive Vice President at Elanco Animal Health, disposed of 4,747 shares of common stock on March 1, 2025, to cover tax obligations.

Grace McArdle, EVP of Manufacturing and Quality at Elanco Animal Health, reports the disposal of 3,430 shares of common stock to cover tax obligations.

Ellen de Brabander, an Executive Vice President at Elanco Animal Health Inc, disposed of 15,049 shares of common stock on March 1, 2025, to satisfy tax withholding obligations.

Elanco Animal Health Inc. Executive Vice President Ramiro Martin Cabral disposed of 11,749 shares of common stock on March 1, 2025, to cover tax obligations.

David S. Kinard, Executive Vice President of Elanco Animal Health, reports a transaction involving common stock on March 1, 2025.

Elanco Animal Health's CEO, Jeffrey N. Simmons, acquired deferred stock units representing the right to receive common stock or cash equivalent, according to a recent SEC filing.

Rajeev A. Modi, an Executive Vice President at Elanco Animal Health, reported the acquisition of deferred stock units convertible to common stock, according to a Form 4 filing with the SEC.

James M. Meer, Chief Accounting Officer of Elanco Animal Health, reports acquisition of shares and a disposition to cover tax obligations, along with a correction to a previous filing.

David S. Kinard, an executive at Elanco Animal Health, reports the acquisition and disposal of company stock on February 19, 2025.

Elanco Animal Health's Executive Vice President, Ramiro Martin Cabral, reports the acquisition and disposal of company stock.

Todd S. Young, Executive Vice President and CFO of Elanco Animal Health, reports acquisition and disposal of company stock, resulting in adjusted beneficial ownership.

Jose Manuel Correia de Simas, an Executive Vice President at Elanco Animal Health, reported the acquisition and disposal of company stock on February 19, 2025.

Elanco Animal Health CEO Jeffrey Simmons reports acquisition and disposal of company stock, including corrections to previous filings and participation in the Employee Stock Purchase Plan.

EVP Grace McArdle reports acquisition of 8,025 shares and disposition of 2,596 shares of Elanco Animal Health Inc. common stock.

Ellen de Brabander, an Executive Vice President at Elanco Animal Health Inc, reported the acquisition and disposal of company stock on February 19, 2025.

Elanco Animal Health Inc. executive Rajeev A. Modi reports acquisition and disposal of common stock, resulting in adjustments to his beneficial ownership.

Shiv O'Neill, GC AND CORP SEC of Elanco Animal Health Inc, reports the acquisition and disposal of common stock on February 19, 2025.

Elanco Animal Health's CEO, Jeffrey N. Simmons, acquired deferred stock units representing the right to receive common stock or cash equivalent, according to a recent SEC Form 4 filing.